Michael Bolaris

Use of Antistaphylococcal  -Lactams to Increase Daptomycin Activity in Eradicating Persistent Bacteremia Due to Methicillin-Resistant Staphylococcus aureus: Role of Enhanced Daptomycin Binding

Abhay Dhand, Arnold S. Bayer, Joe Pogliano et al. · Clinical Infectious Diseases · 2011 · 254 citations · Full text

Life Sciences, Infectious Diseases, Microbiology +17

Decolonization to Reduce Postdischarge Infection Risk among MRSA Carriers

Susan S. Huang, Raveena Singh, James A. McKinnell et al. · New England Journal of Medicine · 2019 · 171 citations · Full text

Public Health, Infectious Diseases, Microbiology +16

Molecular epidemiology and characterization of multiple drug-resistant (MDR) clinical isolates of Acinetobacter baumannii

Sherief El‐Shazly, Ali A. Dashti, Leila Vali et al. · International Journal of Infectious Diseases · 2015 · 77 citations · Full text

Life Sciences, Infectious Diseases, Microbiology +16

The Hyr1 protein from the fungus Candida albicans is a cross kingdom immunotherapeutic target for Acinetobacter bacterial infection

Priya Uppuluri, Lin Lin, Abdullah Alqarihi et al. · PLoS Pathogens · 2018 · 59 citations · Full text

Life Sciences, Immunology, Microbiology +17

Cost–benefit analysis comparing trough, two-level AUC and Bayesian AUC dosing for vancomycin

Brian V. Lee, Gary Fong, Michael Bolaris et al. · Clinical Microbiology and Infection · 2020 · 45 citations · Full text

Pharmacy, Clinical Pharmacokinetics, Pharmacokinetics +15